The effect of itracameral bevacizumab injection on outcome of trabeculectomy
Not Applicable
- Conditions
- primary open angel glaucoma.Primary open-angle glaucoma
- Registration Number
- IRCT2014042617443N1
- Lead Sponsor
- Teharn University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
primary openagle glaucoma candidate for trabeculectomy; pseudoexfoliative glaucoma candidate for trabeculectomy
Exclusion criteria: age<50 ; high risk patients for cardiovascular disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure. Timepoint: before intervention,1 week, 1 month, 3 month and 6 months after intervention. Method of measurement: Goldman aplanation tonometer.
- Secondary Outcome Measures
Name Time Method Bleb morphply. Timepoint: 3 and 6 months after intervention. Method of measurement: morphild grading system.